- Pharmaceutical Executive: November 2023
- Volume 43
- Issue 11
A Peek at Potential
It’s late in the year, which means that it’s time for Pharmaceutical Executive’s annual Pipeline Report.
Also featured in this issue is Pharm Exec’s 22nd annual
While our Audit examines past performance, our Pipeline Report details future potential. As the year nears its close, these two analyses, juxtaposed together, offer an interesting snapshot of where the industry has been and where it is headed.
Perhaps not surprisingly, the topic of artificial intelligence (AI) makes another appearance this month. As one of the most exciting trends in technology in recent years, pharma companies are fast at work trying to figure out ways to incorporate AI into various key processes it could influence for the better. While this can lead to some great innovations, there is also risk. Experts Alan Marcus and Jeff Policastro, both from LabVantage Solutions,
Articles in this issue
almost 2 years ago
2024 Pipeline Report: First-World Focusalmost 2 years ago
Pharma Should Embrace the Single Sign-Onalmost 2 years ago
22nd Annual Industry Audit: The Pharma Value Picturealmost 2 years ago
Changing the Paradigm in AI Implementationalmost 2 years ago
Reading the Tea Leaves for Biotech As 2024 Approachesalmost 2 years ago
Pharma Giving is Still Strong Despite Post-Pandemic Shiftsalmost 2 years ago
Equity for Women in Healthcare: 131 Years is Too Long to Waitalmost 2 years ago
Pharmaceutical Executive: November 2023 Issue (PDF)Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.